Premium
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU
Author(s) -
Ertaş Ragıp,
Hawro Tomasz,
Altrichter Sabine,
Özyurt Kemal,
Erol Kemal,
Ketenci Ertaş Şule,
Maurer Marcus
Publication year - 2020
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14033
Subject(s) - omalizumab , anti nuclear antibody , medicine , immunology , antibody , dermatology , immunoglobulin e , autoantibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom